ArmInfo.A medicinal vaccine against human papillomavirus, which will be used in Armenia in December 2017, was produced by the American company Merc on October 12, 2016 with a shelf life of three years.
ArmInfo.Armenia will start vaccination of girls at the age of 13 from virus papilla December 2017 to prevent cervical cancer. The decision on this was taken at a government meeting on November 9.As the Armenian Minister of Health Levon Altunyan stated, starting from the second decade of December of this year to the middle of 2018, vaccination will be carried out.